A major hurdle in new drug development is solubility – the drug's ability to dissolve in the body. If not soluble, a drug cannot be absorbed into the body. More than 30 percent of new drug breakthroughs have poor solubility. The DOWPHARMA^SM team providing BioAqueous^SM solubilization services is working with pharmaceutical companies to create more soluble versions of their new drugs. The team alters the shape, size or surface area of the drug particles to improve solubility.

< back

What Do You Think?

DOWPHARMA^SM and BioAqueous^SM are service marks of The Dow Chemical Company.